Mabpharm Limited (HKG:2181)

Mabpharm Revenue

In the year 2025, Mabpharm had annual revenue of 646.10M CNY with 150.20% growth. Mabpharm had revenue of 371.91M in the half year ending December 31, 2025, with 762.08% growth.

• Revenue: 646.10M CNY
• Revenue Growth: +150.20%
• P/S Ratio: 2.52
• Revenue / Employee: 1.66M CNY
• Employees: 389
• Market Cap: 1.81B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	646.10M	387.87M	150.20%
Dec 31, 2024	258.23M	171.07M	196.27%
Dec 31, 2023	87.16M	31.24M	55.87%
Dec 31, 2022	55.92M	-26.96M	-32.53%
Dec 31, 2021	82.88M	-	-